Literature DB >> 1500680

Protein C in patients with alcoholic cirrhosis and other liver diseases.

H Bell1, O R Odegaard, T Andersson, N Raknerud.   

Abstract

The coagulation inhibitor protein C was measured in 151 patients with various liver diseases. The protein C level was significantly decreased in patients with alcoholic cirrhosis (n = 73) compared to patients with steatosis (n = 24) (40 +/- 2%) vs. 88 +/- 4%, mean S.E., p less than 0.001). It was also decreased in cases of acute liver damage (n = 8) and in patients with non-alcoholic cirrhosis (n = 15) (35 +/- 7% and 36 +/- 4%, respectively). A significant correlation was found between protein C and Normotest, antithrombin, heparin cofactor II, (r = 0.83, r = 0.82, r = 0.81, respectively, p less than 0.001). There was also a significant correlation between protein C and serum concentrations of albumin (r = 0.61, p less than 0.001), but a negative association to bilirubin (r = -0.56). No significant association was found between protein C and aspartate aminotransferase, alaline aminotransferase, and gamma-glutamyltranspeptidase. In conclusion, protein C is low in advanced liver diseases and gives the same amount and type of information as Normotest, antithrombin and heparin cofactor II.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500680     DOI: 10.1016/0168-8278(92)90153-g

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  2 in total

1.  Elevated plasma protein C levels correlate with the presence of fatty liver (NASH and NAFLD).

Authors:  N Assy; S Schlesinger; O Hussein
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

2.  Impact of sustained virus elimination on natural anticoagulant activity in patients with chronic viral hepatitis C.

Authors:  Aida Saray; Rusmir Mesihović; Zora Vukobrat-Bijedić; Srđan Gornjaković; Nenad Vanis; Amila Mehmedović; Vedad Papović; Sanjin Glavaš
Journal:  Bosn J Basic Med Sci       Date:  2013-05       Impact factor: 3.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.